The Strength Training and Remicade Study

University of Arizona1 site in 1 country35 target enrollmentMarch 2004

ConditionsRheumatoid Arthritis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Rheumatoid Arthritis
Sponsor: University of Arizona
Enrollment: 35
Locations: 1
Primary Endpoint: Strength
Status: Completed
Last Updated: 19 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To assess the effects of a 16-week individualized, intensive strength training program in patients with rheumatoid arthritis. Primary and secondary outcomes include: strength and body composition, function, disease activity, pain, quality of life.

We hypothesized that improvements would be seen in all of the above outcomes.

Registry

clinicaltrials.gov

Start Date

March 2004

End Date

January 2005

Last Updated

19 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

University of Arizona

Eligibility Criteria

Inclusion Criteria

•Males and females with RA
•Over 18 years of age
•ACR Functional Class I and II
•Taking Remicade \>4 months

Exclusion Criteria

•Presence of comorbid conditions contraindicated to exercise, including, but not limited to:
•heart disease
•severe osteoporosis: (if \>50 years): T score \< -3.0 for hip or spine excluded; T score \<-2.5 for hip or spine w/o current treatment)
•(all potential subjects) previous non-traumatic fractures
•uncontrolled BP
•Regular use of assistive walking device which would interfere with ability to lift weights
•Currently or within the last 3 months participating in aerobic exercise \> 150 minutes a week
•Currently or within the last 3 months participating in any regular strength training activities
•Presence of neurological impairment that directly limits ability to perform exercise
•Participation in concurrent exercise study